MAP3K14


Description

The MAP3K14 (mitogen-activated protein kinase kinase kinase 14) is a protein-coding gene located on chromosome 17.

MAP3K14, also known as NF-kappa-B-inducing kinase (NIK), is a MAP kinase kinase kinase enzyme encoded by the MAP3K14 gene in humans. It acts as a serine/threonine protein-kinase, binding to TRAF2 and stimulating NF-κB activity. NIK is a critical kinase in the alternative NF-κB activation pathway and shares sequence similarity with other MAPKK kinases. It participates in an NF-κB-inducing signaling cascade common to receptors of the tumor-necrosis/nerve-growth factor (TNF/NGF) family and the interleukin-1 type-I receptor. MAP3K14 interacts with CHUK, IKK2, and TRAF2.

MAP3K14, also known as NF-κB-inducing kinase (NIK), is a key player in the non-canonical NF-κB signaling pathway. It exclusively activates NF-κB and its transcriptional activity. Through phosphorylation of CHUK/IKKA, it promotes the proteolytic processing of NFKB2/P100, ultimately leading to NF-κB activation via the non-canonical pathway. This pathway regulates genes essential for B-cell survival, lymphoid organogenesis, and immune response. MAP3K14's action might be receptor-selective.

MAP3K14 is also known as FTDCR1B, HS, HSNIK, IMD112, NIK.

Associated Diseases


Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.